近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Corvetta, D. , Chayka, O. , Gherardi, S. , D'Acunto, CW. , et al. (2013) 'Physical interaction between MYCN oncogene and polycomb repressive complex 2 (PRC2) in neuroblastoma: Functional and therapeutic implications'. Journal of Biological Chemistry, 288 (12). pp. 8332 - 8341. doi: 10.1074/jbc.M113.454280 Download publication Santilli, G. , Thrasher, AJ. , Piotrowska, I. , Cantilena, S. , et al. (2013) 'Polyphenon E enhances the antitumor immune response in neuroblastoma by inactivating myeloid suppressor cells'. Clinical Cancer Research, 19 (5). pp. 1116 - 1125. doi: 10.1158/1078-0432.CCR-12-2528 Download publication Sottile, F. , Gnemmi, I. , Cantilena, S. , D'Acunto, WC. and Sala, A. (2012) 'A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma'. Oncotarget, 3 (5). pp. 535 - 545. Download publication Sala, A. (2012) 'c-MYB and TGF-β: EMT's dynamic duo in breast cancer'. Cell Cycle, 11 (1). pp. 17. doi: 10.4161/cc.11.1.18733 Cantilena, S. , Pastorino, F. , Pezzolo, A. , Chayka, O. , et al. (2011) 'Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas'. Oncotarget, 2 (12). pp. 976 - 983. Download publication Chaiwatanasirikul, KA. and Sala, A. (2011) 'The tumour-suppressive function of CLU is explained by its localisation and interaction with HSP60'. Cell Death and Disease. doi: 10.1038/cddis.2011.99 Download publication Gualdrini, F. , Corvetta, D. , Cantilena, S. , Chayka, O. , et al. (2010) 'Addiction of MYCN amplified tumours to B-MYB underscores a reciprocal regulatory loop'. Oncotarget, 1 (4). pp. 278 - 288. Bettuzzi, S. , Davalli, P. , Davoli, S. , Chayka, O. , et al. (2009) 'Genetic inactivation of ApoJ/clusterin: Effects on prostate tumourigenesis and metastatic spread'. Oncogene, 28 (49). pp. 4344 - 4352. doi: 10.1038/onc.2009.286 Sala, A. , Bettuzzi, S. , Pucci, S. , Chayka, O. , et al. (2009) 'Regulation of CLU gene expression by oncogenes and epigenetic factors implications for tumorigenesis'. Advances in Cancer Research, 105 (1). pp. 115 - 132. doi: 10.1016/S0065-230X(09)05007-6 Chayka, O. , Corvetta, D. , Dews, M. , Caccamo, AE. , et al. (2009) 'Clusterin, a haploinsufficient tumor suppressor gene in neuroblastomas'. Journal of the National Cancer Institute, 101 (9). pp. 663 - 677. doi: 10.1093/jnci/djp063 Download publication Schwab, R. , Bussolari, R. , Corvetta, D. , Chayka, O. , et al. (2008) 'Isolation and functional assessment of common, polymorphic variants of the B-MYB proto-oncogene associated with a reduced cancer risk'. Oncogene, 27 (20). pp. 2929 - 2933. doi: 10.1038/sj.onc.1210947 Schwab, R. , Caccamo, A. , Bettuzzi, S. , Anderson, J. and Sala, A. (2007) 'B-MYB is hypophosphorylated and resistant to degradation in neuroblastoma: Implications for cell survival'. Blood Cells, Molecules, and Diseases, 39 (3). pp. 263 - 271. doi: 10.1016/j.bcmd.2007.04.006 Santilli, G. , Aronow, BJ. and Sala, A. (2003) 'Essential requirement of apolipoprotein J (clusterin) signaling for IkappaB expression and regulation of NF-kappaB activity'. Journal of Biological Chemistry, 278 (40). pp. 38214 - 38219. doi: 10.1074/jbc.C300252200